3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
2
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Biopsy
17
Specimen Handling
16
Magnetic Resonance Spectroscopy
15
Cyclophosphamide
14
Rituximab
12
obinutuzumab
8
Lenalidomide
8
fludarabine
7
Prednisone
7
pembrolizumab
6
Nuclear Medicine Department, Hospital
6
Doxorubicin
5
glofitamab
4
fludarabine phosphate
4
X-Rays
4
Vincristine
4
Tacrolimus
4
Mycophenolic Acid
4
Etoposide
4
Busulfan
4
venetoclax
3
trametinib
3
sapanisertib
3
ibrutinib
3
copanlisib
3
acalabrutinib
3
Whole-Body Irradiation
3
Nivolumab
3
GSK2636771
3
Crizotinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Erlotinib Hydrochloride
×
30 days
×
Clear all
No trials found.